Lycia Therapeutics Inc. (LYCA) Stock Ticker
LYCA right now
Market factors today
Unlock the full LYCA picture
About Lycia Therapeutics Inc.
Lycia Therapeutics, Inc. operates as a clinical-stage biotechnology company. It engages in the discovery and development of novel therapeutics designed to degrade disease-causing extracellular proteins, with an initial focus on addressing autoimmune, inflammatory, and allergic diseases. The company was founded in 2019 and is headquartered in South San Francisco, CA.
LYCA stock facts
| Ticker symbol | LYCA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $1.4B |
| CEO | Aetna Wun Trombley |
| Employees | 65 |
| Headquarters | South San Francisco, CA, US |
| IPO date | 2026-10-23 |
| Website | lyciatx.com |
What you can see for LYCA on Tickr
Live LYCA price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the LYCA report.
Rankings
FAQ
What is the ticker symbol for Lycia Therapeutics Inc.?
The ticker symbol for Lycia Therapeutics Inc. is LYCA, listed on the NASDAQ.
What is LYCA?
Lycia Therapeutics, Inc. operates as a clinical-stage biotechnology company. It engages in the discovery and development of novel therapeutics designed to degrade disease-causing extracellular proteins, with an initial focus on addressing autoimmune, inflammatory, and allergic diseases. The company was founded in 2019 and is headquartered in South San Francisco, CA.